CYP19A1 and neoplasm: Finally, the ER+/ERαKD mouse tumor model, combined with FDG and 11C]-MET PET imaging, would represent a valuable test bench for new ER-specific therapies [32,33] or for optimizing the dose regimen and administration protocols of existing antiestrogen or aromatase inhibitor therapies.